Pediatrics Doctors in New Smyrna Beach, FL Accepting Medicare

7 Pediatrics doctors found. Showing 1 - 7

Dr. Thomas G. Mc Loughlin Jr., M.D. Pediatrics - Pediatric Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1115 S Dixie Fwy, New Smyrna Beach, FL 32168 Phone: 386-463-5323

Dr. Roxanne L Edwards, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2434 S Glencoe Rd, New Smyrna Beach, FL 32168 Phone: 285-424-9740

Dr. Robert Carithers, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 605 S Orange St, New Smyrna Beach, FL 32168 Phone: 386-427-4882    Fax: 386-426-1260

Kwang Joon Choi, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 245 N Causeway, New Smyrna Beach, FL 32169 Phone: 386-426-5800    Fax: 386-426-1416

Cristina Garcia, Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 317 S Dixie Fwy, New Smyrna Beach, FL 32168 Phone: 386-424-1414    Fax: 386-424-9130

Dr. Priscilla Luong, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 161 N Causeway, New Smyrna Beach, FL 32169 Phone: 386-424-1584    Fax: 386-410-4800

Dr. Christine Lundberg Williams, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 300 2nd Street, New Smyrna Beach, FL 32168 Phone: 914-582-6639

News Archive

Pulsar Vascular reaches target enrollment in PulseRider clinical trial for treatment of intracranial aneurysms

Pulsar Vascular, an innovative medical device company, focused on breakthrough technology in the neurovascular space, announced today that they have reached the target enrollment in their clinical trial for PulseRider, the company's lead product.

Call for increased screening and faster testing for drug-resistant tuberculosis

Johns Hopkins experts in the prevention and treatment of multidrug-resistant tuberculosis are calling for increased screening and more rapid testing of the 9 million people worldwide estimated to be infected each year with TB, and now at risk for this form of the highly contagious lung disease. The call follows results of a survey showing that the harder-to-treat TB variants are much more widespread than previously thought.

BDSI to discuss planned BEMA Granisetron IND with the FDA

BioDelivery Sciences International, Inc. announced that the company has been granted a meeting with the U.S. Food and Drug Administration (FDA) to discuss the planned Investigational New Drug (IND) application for BDSI's antiemetic (anti-nausea and vomiting) product candidate, BEMA Granisetron. The meeting will take place on March 17, 2010. The company will discuss with the FDA clinical development and regulatory plans for BEMA Granisetron, which is anticipated to enter Phase 1 studies in the second quarter of 2010.

Researchers test clinical safety of gene-based treatment for achromatopsia

People with complete color blindness are born unable to distinguish colors. They see less sharply and are highly sensitivity to glare.

Maternal smoking replaces stomach sleeping as the greatest modifiable risk factor for SIDS

A study in the April 1 issue of the journal SLEEP shows that maternal smoking is associated with an impaired infant arousal process that may increase the risk for sudden infant death syndrome (SIDS).

Read more Medical News

› Verified 8 days ago